2017 American Transplant Congress
Plasma Cell Hepatitis in Primary Sclerosing Cholangitis Patients: 15-Year Experience at a Transplant Center.
Background: Plasma cell hepatitis (PCH) is an uncommon liver graft dysfunction which occurs in liver transplant (LT) recipients of different etiologies other than autoimmune hepatitis.…2017 American Transplant Congress
Share35: Increasing Biliary Complications and Healthcare Resources?
Data has shown that major outcomes of liver transplant post-Share35 have been equivalent to pre-Share35, despite organs accumulating longer CIT and traveling further.The PURPOSE of…2017 American Transplant Congress
Cardiovascular Events Are a Substantial and Increasing Cause of Graft Loss in Liver Transplant Recipients.
Pharmacy, Transplant, MUSC, Charleston, SC
Purpose: The overall 1- and 3- year graft survival rates following liver transplant are 89.1% and 79.9%, respectively. While these numbers have vastly improved, they…2017 American Transplant Congress
Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.
Background: Enhanced recovery after surgery protocol has proven its efficacy in many surgery fields in controlling pain and promoting early recovery . The implication of…2017 American Transplant Congress
Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial.
Background. Long-term outcomes under EVR with MPA and no calcineurin inhibitor are undocumented after liver tx.Methods. CERTITUDE is a prospective, multicenter, observational study of liver…2017 American Transplant Congress
Pre-TACE Immune Status Correlates with Treatment Response and Tumor Biology in HCC as a Bridge to Transplant.
Purpose:Immune factors are pivotal against disease progression after transplant in hepatocellular carcinoma (HCC). With chemoembolization (TACE) as a bridge to liver transplant, this study compares…2017 American Transplant Congress
Neutropenia in Kidney and Liver Transplant Recipients: Risk Factors and Consequences.
Aim: This study aimed to: 1) Define the risk factors associated with neutropenia within the first year post kidney or liver transplantation; 2) Describe the…2017 American Transplant Congress
Identifying Independent Risk Factors for Graft Loss After Primary Liver Transplantation: A Propensity Score Matched Analysis.
Core Facility Quality Management Transplantation, Hannover Medical School, Hannover, Germany
This study aims to identify independent risk factors for graft loss after primary liver transplantation beyond the occurrence of hepatic artery thrombosis. Graft loss was…2017 American Transplant Congress
Recovery from Hypophosphatemia as a Predictor of Post-Operative Morbidity in Live Donor Hepatectomy.
OBJECTIVE: Live donor hepatectomy (LDH) is associated with significant post-operative hypophosphatemia (POH), which is associated with liver regeneration. We investigated whether the rate of recovery…2017 American Transplant Congress
Use of Biodegradable Stents for the Treatment of Anastomotic Biliary Strictures in Pediatric Liver Transplant Patients.
Objectives To evaluate feasibility, safety and mid-time outcome of pediatric liver transplant patients treated with a biodegradable biliary stent for anastomotic biliary strictures.Methods Retrospective study…
- « Previous Page
- 1
- …
- 140
- 141
- 142
- 143
- 144
- …
- 180
- Next Page »